FDA lets Novartis off the hook in Zolgensma data manipulation
admin 31st March 2020 Uncategorised 0When Novartis’ Zolgensma data manipulation problem first went public last August, an angry FDA said it would consider possible civil or criminal penalties. But it looks like neither of those is going to happen. Despite a Form 483 citation for
read more